PML and acute promyelocytic leukemia: This portability empowers genomic diagnostics in diverse clinical settings, including mobile health facilities and remote or rural healthcare centers, thereby enhancing access to diagnostic tools for structural abnormalities, such as the PML::RARA fusion in APL patients, worldwide.